Active pharmaceutical ingredients (API) and excipient characterization in transdermal formulations are critical to ensure their efficacy, safety, and overall performance. CD Formulation has decades of experience in developing transdermal formulations and provides you with API and excipient characterization.
Excipients are non-active components found in drug formulations. They work alongside the active ingredient (API) to enhance various aspects of the drug, such as its physical properties, stability, solubility, and release characteristics. The API is the key ingredient in drug formulations. How the API interacts with excipients is crucial for the effectiveness of transdermal formulations. For example, the ability of the active pharmaceutical ingredient (API) to dissolve, spread, and pass through the excipients has a direct effect on how quickly the drug is released and how effectively it is absorbed through the skin. Hence, it is crucial to thoroughly evaluate how the active pharmaceutical ingredient (API) interacts with other components in transdermal formulations to attain the best therapeutic results and medication effects.
Determine the molecular configuration by using techniques such as spectroscopy (including NMR and IR), mass spectrometry, or X-ray crystallography to identify the chemical structure.
Assess the cleanliness of the API to confirm it complies with pharmacopoeial or regulatory requirements. Methods such as HPLC or GC are commonly employed for this purpose.
Find out how well the active pharmaceutical ingredient dissolves in different solvents to improve the development of formulations.
Assess the durability of the active pharmaceutical ingredient (API) in a product over a period, taking into account variables like pH, temperature, and exposure to light.
Improve the solubility of the active pharmaceutical ingredient (API) in a formulation by adding excipients like surfactants or solubilizers.
Assess additives that can improve the ability of the active pharmaceutical ingredient to penetrate the skin barrier.
Examine how the active pharmaceutical ingredient (API) and other ingredients interact to ensure the stability and effectiveness of the formulation.
Assess the physical compatibility of excipients with patch components such as the backing layer and adhesive to avoid any potential issues related to physical instability or drug delivery.
Fig.1 Flow chart of transdermal formulation API and excipient characterization. (CD Formulation)
Technologies | Description |
---|---|
Spectroscopy | UV-Vis, FT-IR, and NMR for structural analysis and purity determination. |
Chromatography | HPLC, GC for quantification, impurity analysis, and stability studies. |
Thermal analysis | DSC (Differential Scanning Calorimetry), TGA (Thermogravimetric Analysis) for stability and compatibility assessment. |
Microscopy | SEM (Scanning Electron Microscopy), and TEM (Transmission Electron Microscopy) for particle characterization and morphological studies. |
Technology: Methods to API and excipient characterization
Journal: Chinese Herbal Medicines
IF: 3.8
Published: 2021
Results: The Box–Behnken design was an efficient tool in optimizing the three variables used to prepare curcumin TDDS by studying their effect on the quality attributes and dissolution behavior of the prepared curcumin-loaded transdermal films. The optimized formulation showed good physicochemical and mechanical properties as well as enhanced dissolution characteristics.
Fig.2 IR spectra of curcumin (A), transdermal patch (B), ethyl cellulose (C), hydroxy propyl methyl cellulose (D), polyethylene glycol 400 (E), and dibutyl phthalate (F). (Priyanka Kriplani, et al. 2021)
Effective characterization of transdermal API and excipients helps optimize formulation, improve manufacturing efficiency, and ultimately ensure the clinical success of transdermal products. If you have any needs, please feel free to contact us and our colleagues will contact you within three working days.
References